Sign Up to like & get
recommendations!
0
Published in 2017 at "Human immunology"
DOI: 10.1016/j.humimm.2016.10.007
Abstract: Patients with colorectal cancer (CRC) have been shown to have elevated levels of circulating prostaglandin E2 (PGE2) which promotes cancer progression and suppresses T cell immune responses. In this study we evaluated whether signaling responses…
read more here.
Keywords:
colorectal cancer;
circulating prostaglandin;
signaling responses;
cancer ... See more keywords